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Background: Pre-pregnancy hypertension and diabetes mellitus, multiple gestations, prior preeclampsia, 
are significant risk factors for preeclampsia. Whether altered maternal levels of angiogenic factors 
contribute to increased preeclampsia risk in these conditions is unknown. Our objective was to compare 
maternal serum angiogenic biomarker levels in women with major risk factors for preeclampsia and 
healthy controls. 
 
Methods: Women presenting for prenatal care were enrolled if they had one of the following 
preeclampsia risk factors: pre-pregnancy hypertension and/or diabetes mellitus, nulliparity with pre-
pregnancy BMI>30, multiple gestations, or prior preeclampsia. Healthy control pregnancies without 
these risk factors were enrolled for comparison. Maternal serum samples were collected at 3 pre-
specified gestational windows between 23 and 36 weeks gestation. sFlt1, sEng, and PlGF were measured 
by ELISA. The (sFlt1+sEng):PlGF ratio was calculated and compared for each risk group at each 
gestational window.  
 
Results: Gestational patterns of angiogenic biomarkers differed in high-risk groups vs. healthy control 
subjects. The angiogenic ratio (sFlt1+sEng):PlGF was higher for all high risk groups except 
obesity/nulliparity as compared with healthy control subjects after 28 weeks gestation. Biomarker ratio 
levels were highest in subjects with MG and prior PE, and differences from the health control group 
became more pronounced as gestation progressed. Women with hypertension/diabetes had more 
subtle differences as compared with healthy control subjects.  
 
Conclusion: Women with preeclampsia risk factors had higher angiogenic ratios compared with healthy 
control women. This study illuminates the interplay between risk factors and placental angiogenic 
biomarkers in the pathogenesis of preeclampsia. 
